echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Chemicals Industry > Chemical Technology > Issue 19/2021 - New anti-implantable foreign body reaction material was successfully developed

    Issue 19/2021 - New anti-implantable foreign body reaction material was successfully developed

    • Last Update: 2022-11-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    A new type of anti-implantable foreign body reaction material was successfully developed

    Recently, based on biomimetic design, Professor Liu Runhui's research group of Professor Liu Runhui of East China University of Science and Technology has developed a new anti-implantable foreign matter reaction polymer material with simple structure, high water solubility and easy to prepare in large quantities - polyDL-serine (PSer).

    Based on the biomimetic design, the research team combined the high content of L-serine in sericin and D-serine, which is an important neurotransmitter in the human body, to discover a new generation of anti-foreign body reaction material PSer
    .

    PSer hydrogel does not cause a significant inflammatory response after implantation in mice and is able to resist fibrocyst encapsulation for at least 7 months, which is superior to the polyethylene glycol implantation control group
    currently widely used in biomaterials.
    Studies at the protein level and gene level revealed that the reason for the low foreign body reaction of PSer hydrogel is that it does not cause overexpression
    of cytokines and pro-inflammatory genes in surrounding tissues.
    This kind of new polymer material with good biological safety, easy synthesis and mass preparation, and excellent anti-foreign body reaction has broad application prospects in implanted biomaterials and devices, drug delivery and other related fields, which brings new ideas
    for solving the foreign body reaction of implant materials that is common in clinical practice.



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.